Carolinas Wealth Consulting’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-93
Closed -$1.39K 165
2025
Q1
$1.39K Hold
93
﹤0.01% 866
2024
Q4
$1.61K Sell
93
-15
-14% -$289 ﹤0.01% 871
2024
Q3
$2K Buy
108
+21
+24% +$422 ﹤0.01% 818
2024
Q2
$1.77K Sell
87
-12
-12% -$212 ﹤0.01% 822
2024
Q1
$1.69K Sell
99
-1
-1% -$16 ﹤0.01% 815
2023
Q4
$1.77K Sell
100
-8
-7% -$161 ﹤0.01% 757
2023
Q3
$2.31K Buy
108
+24
+29% +$589 ﹤0.01% 726
2023
Q2
$1.95K Buy
+84
New +$1.9K ﹤0.01% 813
2023
Q1
Sell
-32
Closed -$649 1071
2022
Q4
$649 Sell
32
-3
-9% -$58 ﹤0.01% 962
2022
Q3
$0 Hold
35
﹤0.01% 884
2022
Q2
$1K Hold
35
﹤0.01% 801
2022
Q1
$1K Hold
35
﹤0.01% 831
2021
Q4
$1K Buy
35
+2
+6% +$52 ﹤0.01% 867
2021
Q3
$1K Hold
33
﹤0.01% 837
2021
Q2
$1K Hold
33
﹤0.01% 847
2021
Q1
$1K Sell
33
-1
-3% -$34 ﹤0.01% 853
2020
Q4
$1K Sell
34
-7
-17% -$143 ﹤0.01% 780
2020
Q3
$1K Buy
+41
New +$860 ﹤0.01% 802

Other funds holding CLB

Carolinas Wealth Consulting's CLB Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 93 shares — an estimated $1.39K sold.

Carolinas Wealth Consulting first reported a position in CLB in Q3 2020 and held it in 18 quarters. The position peaked at $2.31K in Q3 2023. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 93 Core Laboratories shares in Q2 2025, an estimated $1.39K.
  • Carolinas Wealth Consulting first reported a position in Core Laboratories in Q3 2020 and held it in 18 quarters.
  • Carolinas Wealth Consulting's Core Laboratories position peaked at $2.31K in Q3 2023.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.